Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis
Derek Dang, Akash Deogharkar, John McKolay, Kyle Smith, Pooja Panwalkar, Simon Hoffman, Wentao Tian, Sunjong Ji, Ana Paula Azambujá, Siva Kumar Natarajan, Joanna Lum, Jill Bayliss, Katie Manzeck, Stefan R. Sweha, Erin Hamanishi, Matthew Pun, Diya Patel, Sagar Rau, Olamide Animasahun, Abhinav Achreja, Martin P. Ogrodzinski, Jutta Diessl, Jennifer Cotter, Debra Hawes, Fusheng Yang, Robert Doherty, Andrea Franson, Allison R. Hanaford, Charles G. Eberhart, Eric H. Raabe, Brent A. Orr, Robert J. Wechsler‐Reya, Brandon Chen, Costas A. Lyssiotis, Yatrik M. Shah, Sophia Y. Lunt, Ruma Banerjee, Alexander R. Judkins, John R. Prensner, Carl Koschmann, Sebastian M. Waszak, Deepak Nagrath, Marcos Simões-Costa, Paul A. Northcott, Sriram Venneti
Topics & Concepts
Isocitrate dehydrogenaseGroup (periodic table)IDH1MedulloblastomaBiologyDehydrogenaseCancer researchMolecular biologyBiochemistryChemistryEnzymeMutationGeneOrganic chemistryGlioma Diagnosis and Treatmentinterferon and immune responsesCancer-related Molecular Pathways